Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

The document explains how to identify different hair problems using a microscope.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

5α-Reductase inhibitors don't cause depression.

Male pattern baldness may be linked to prostate cancer risk.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Some common medications can lower PSA levels in 45-year-old German men.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Waking up to urinate at night (nocturia) is linked to higher death rates, but the exact reason is unknown.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Finasteride doesn't harm bone density in older men with BPH.

Dutasteride may help shrink prostate cancer tumors.